Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07105033 · ClinicalTrials.gov registry record · NA

Development and Pilot Trial of Focused ACT (FACT) for Patients With Advanced Cancer

A NA study of Advanced Cancer, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT07105033 is a NA study of Advanced Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 70 participants, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07105033, a NA study of Advanced Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

To learn about the effects of an intervention program called Focused Acceptance and Commitment Therapy (FACT) on the level of anxiety patients diagnosed with cancer feel about death. To learn if an intervention program called Focused Acceptance and Commitment Therapy (FACT), designed to help reduce death-related anxiety, is effective and acceptable to patients diagnosed with advanced cancer.

Conditions Studied

Interventions

  • BEHAVIORAL FACT Session
  • BEHAVIORAL Enhanced Usual Care and Assessments

Study Locations (1)

Texas

  • The University of Texas M. D. Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2025-07-21
Est. Completion 2029-12-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT07105033

The ClinicalTrials.gov registry entry for NCT07105033 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (72% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Cancer appearing as the primary indexed condition, and to 2 interventions - of which FACT Session is the first listed.

NCT07105033 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07105033 about?

NCT07105033 is a clinical study titled "Development and Pilot Trial of Focused ACT (FACT) for Patients With Advanced Cancer". To learn about the effects of an intervention program called Focused Acceptance and Commitment Therapy (FACT) on the level of anxiety patients diagnosed with cancer feel about death. To learn if an intervention program called Focused Acceptance and Commitment Therapy (FACT), designed to help reduce...

What is the current status of trial NCT07105033?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-07-21. Estimated completion is 2029-12-31.

What conditions does trial NCT07105033 study?

This clinical trial studies the following conditions: Advanced Cancer.

What interventions are being tested in trial NCT07105033?

The interventions under investigation include: FACT Session (BEHAVIORAL), Enhanced Usual Care and Assessments (BEHAVIORAL).

Who is sponsoring clinical trial NCT07105033?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07105033 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Advanced Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.